{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:18:53Z","timestamp":1789841933637,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01 ES002710"],"award-info":[{"award-number":["R01 ES002710"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"NIEHS","doi-asserted-by":"publisher","award":["P42 ES004699"],"award-info":[{"award-number":["P42 ES004699"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"West Coast Central Comprehensive Metabolomics Center","award":["U24 DK097154"],"award-info":[{"award-number":["U24 DK097154"]}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21 AR062866"],"award-info":[{"award-number":["R21 AR062866"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA172431"],"award-info":[{"award-number":["R01 CA172431"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA164041"],"award-info":[{"award-number":["R01 CA164041"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.lfs.2017.05.018","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T01:31:23Z","timestamp":1494898283000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers"],"prefix":"10.1016","volume":"180","author":[{"given":"Sumanta Kumar","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Ann","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Inceoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5044-9434","authenticated-orcid":false,"given":"Melany","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Morisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1408-8317","authenticated-orcid":false,"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2017.05.018_bb0005","doi-asserted-by":"crossref","first-page":"258209","DOI":"10.1155\/2013\/258209","article-title":"Current perspectives in NSAID-induced gastropathy","volume":"2013","author":"Sinha","year":"2013","journal-title":"Mediators. Inflamm."},{"key":"10.1016\/j.lfs.2017.05.018_bb0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","article-title":"Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient","volume":"120","author":"Laine","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2017.05.018_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00045391-200007020-00008","article-title":"Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System","volume":"7","author":"Singh","year":"2000","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.taap.2015.10.018","article-title":"Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE\u2082 induced pain model","volume":"289","author":"Goswami","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0025","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.116.232108","article-title":"Anti-ulcer efficacy of soluble epoxide hydrolase inhibitor TPPU on diclofenac-induced intestinal ulcers","volume":"357","author":"Goswami","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0035","doi-asserted-by":"crossref","first-page":"487380","DOI":"10.1155\/2012\/487380","article-title":"Gallic acid enriched fraction of Phyllanthus emblica potentiates indomethacin-induced gastric ulcer healing via e-nos-dependent pathway","volume":"2012","author":"Chatterjee","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2017.05.018_bb0040","first-page":"353","article-title":"Role of tumor necrosis factor-\u03b1 in the pathogenesis of indomethacin-induced small intestinal injury in mice","volume":"27","author":"Fukumoto","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2017.05.018_bb0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/toxsci\/kfq226","article-title":"Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice","volume":"118","author":"LoGuidice","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2017.05.018_bb0050","doi-asserted-by":"crossref","first-page":"G990","DOI":"10.1152\/ajpgi.00219.2009","article-title":"Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy","volume":"297","author":"Ramirez-Alcantara","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.cdd.4401436","article-title":"Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis","volume":"11","author":"Tsutsumi","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2017.05.018_bb0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/jpet.110.175778","article-title":"Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice","volume":"338","author":"Kinsey","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0065","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1023\/A:1019633114854","article-title":"Nuclear factor-kappaB and TNF-alpha mediate gastric ulceration induced by phorbol myristate acetate","volume":"47","author":"Takeuchi","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2017.05.018_bb0070","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.141.8.2629","article-title":"Tumor necrosis factor can induce both apoptotic and necrotic form of cell lysis","volume":"141","author":"Laster","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2004.10.019","article-title":"Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor","volume":"505","author":"S\u00e1nchez-Fidalgo","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0080","first-page":"3","article-title":"Apoptosis in the gastric mucosa: molecular mechanisms, basic and clinical implications","volume":"51","author":"Szab\u00f3","year":"2000","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2010.04.013","article-title":"Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis","volume":"49","author":"Pal","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2017.05.018_bb0090","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bcp.2010.01.030","article-title":"Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis","volume":"79","author":"Ishihara","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2017.05.018_bb0100","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2017.05.018_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.prostaglandins.2012.09.003","article-title":"Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice","volume":"104\u2013105","author":"Oni-Orisan","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.lfs.2017.05.018_bb0110","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s10620-012-2217-1","article-title":"Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(\u2212\/\u2212) mice","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2017.05.018_bb0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bcp.12855","article-title":"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor","volume":"81","author":"Lazaar","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0091270010397049","article-title":"Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.110.167544","article-title":"Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis","volume":"334","author":"Luo","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0130","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M113.458414","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue","volume":"288","author":"Bettaieb","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2015.03.022","article-title":"Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice","volume":"286","author":"Harris","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0140","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1021\/jm100691c","article-title":"1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain","volume":"53","author":"Rose","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejps.2012.12.013","article-title":"Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models","volume":"48","author":"Liu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2017.05.018_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FJC.0000000000000094","article-title":"An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension","volume":"64","author":"Ulu","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0155","doi-asserted-by":"crossref","first-page":"23963","DOI":"10.1074\/jbc.274.34.23963","article-title":"Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene","volume":"274","author":"Miyata","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0160","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0165","doi-asserted-by":"crossref","first-page":"E375","DOI":"10.1152\/ajpendo.00131.2009","article-title":"Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase","volume":"297","author":"Luria","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2017.05.018_bb0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.108.143487","article-title":"Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception","volume":"329","author":"Naidu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0310057X8301100211","article-title":"pH testing paper for measurement of intragastric acidity: an assessment","volume":"11","author":"More","year":"1983","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.lfs.2017.05.018_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2013.11.011","article-title":"Protective effect of chelerythrine against ethanol-induced gastric ulcer in mice","volume":"208","author":"Li","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2017.05.018_bb0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.119.3.493","article-title":"Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation","volume":"119","author":"Gavrieli","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-10-39","article-title":"Role of myosin light chain kinase in intestinal epithelial barrier defects in a rat model of bowel obstruction","volume":"10","author":"Wu","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0195","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/abio.1995.1520","article-title":"Improved radio labeled substrates for soluble epoxide hydrolase","volume":"231","author":"Borhan","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0200","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1021\/ac901282n","article-title":"Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"81","author":"Yang","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0205","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/S0024-3205(02)01549-7","article-title":"Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects","volume":"70","author":"Jain","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2017.05.018_bb0210","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0215","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s002280050482","article-title":"Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole","volume":"54","author":"Andersson","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389200033489398","article-title":"The metabolism of diclofenac\u2014enzymology and toxicology perspectives","volume":"4","author":"Tang","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.lfs.2017.05.018_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00365528509095821","article-title":"Pharmacokinetics and metabolism of omeprazole in animals and man\u2014an overview","volume":"108","author":"Reg\u00e5rdh","year":"1985","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.lfs.2017.05.018_bb0230","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0090-9556(24)02970-2","article-title":"Altered pharmacokinetics of omeprazole in cystic fibrosis knockout mice relative to wild-type mice","volume":"32","author":"Tallman","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2017.05.018_bb0235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/ecp.09.8","article-title":"Acid peptic diseases: pharmacological approach to treatment","volume":"2","author":"Mejia","year":"2009","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0240","first-page":"95","article-title":"Localization of omeprazole and metabolites in the mouse","volume":"108","author":"Helander","year":"1985","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.lfs.2017.05.018_bb0245","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1074\/jbc.M800414200","article-title":"Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal","volume":"283","author":"Maity","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0250","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/0044011-200828120-00005","article-title":"Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients: a randomized, double-blind, placebo-controlled study","volume":"28","author":"Gursoy","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.lfs.2017.05.018_bb0255","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.lfs.2017.05.018_bb0260","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"Chiamvimonvat","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0265","first-page":"605101","article-title":"Anti-inflammatory effects of epoxyeicosatrienoic acids","volume":"2012","author":"Thomson","year":"2012","journal-title":"Int. J. Vasc. Med."},{"key":"10.1016\/j.lfs.2017.05.018_bb0270","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.bjp.0701968","article-title":"Increase in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine","volume":"124","author":"Bertrand","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0275","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1046\/j.1365-2036.1998.00409.x","article-title":"TNF-\u03b1 processing enzyme inhibitors prevents aspirin-induced TNFalpha release and protection against mucosal injury in rats","volume":"12","author":"Fiorucci","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0280","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1007\/s10620-007-0172-z","article-title":"Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease","volume":"53","author":"Cury","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2017.05.018_bb0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2036.1999.00442.x","article-title":"Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha","volume":"13","author":"Fiorucci","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2017.05.018_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2017.05.018_bb0295","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2017.05.018_bb0300","first-page":"717","article-title":"Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis","volume":"24","author":"Kaur Saini","year":"2009","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.lfs.2017.05.018_bb0305","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1074\/jbc.M210328200","article-title":"A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical","volume":"278","author":"Biswas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.05.018_bb0310","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3748\/wjg.v9.i8.1767","article-title":"Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats","volume":"9","author":"Guo","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0315","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.1994.tb17048.x","article-title":"Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy","volume":"113","author":"Tomlinson","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.05.018_bb0320","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.91.6.2046","article-title":"Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation","volume":"91","author":"Vane","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2017.05.018_bb0325","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/dmd.115.063339","article-title":"The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain","volume":"43","author":"Kodani","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2017.05.018_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517302400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517302400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:33:06Z","timestamp":1750264386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517302400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":66,"alternative-id":["S0024320517302400"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.05.018","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}